Edoxaban vs Ipilimumab

## Edoxaban vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Edoxaban** and **Ipilimumab**.

## Mechanism of Action

**Edoxaban**: Direct, selective inhibitor of Factor Xa preventing thrombin generation and clot formation.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Edoxaban — 10-14 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Edoxaban — C24H30ClN7O4S; Ipilimumab — N/A.

**Molecular Weight**: Edoxaban — 548.0530 g/mol; Ipilimumab — N/A.

**Type**: Edoxaban — Small molecule; Ipilimumab — Antibody.